Literature DB >> 10370250

Innate and adaptive immune responses can be beneficial for CNS repair.

M Schwartz1, G Moalem, R Leibowitz-Amit, I R Cohen.   

Abstract

The limitation of immune responsiveness in the mammalian CNS has been attributed to the intricate nature of neuronal networks, which would appear to be more susceptible than other tissues to the threat of permanent disorganization when exposed to massive inflammation. This line of logic led to the conclusion that all forms of CNS inflammation would do more harm than good and, hence, the less immune intervention the better. However, mounting evidence indicates that some forms of immune-system intervention can help to protect or restore CNS integrity. We have shown that the innate immune system, represented by activated macrophages, can facilitate the processes of regeneration in the severed spinal cord. More recently, we found that autoimmune T cells that are specific for a component of myelin can protect CNS neurons from the catastrophic secondary degeneration, which extends traumatic lesions to adjacent CNS areas that did not suffer direct damage. The challenge, therefore, is to learn how to modify immune interactions in the traumatized CNS in order to promote its post-injury maintenance and repair.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10370250     DOI: 10.1016/s0166-2236(99)01405-8

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  71 in total

1.  Protective autoimmunity is a physiological response to CNS trauma.

Authors:  E Yoles; E Hauben; O Palgi; E Agranov; A Gothilf; A Cohen; V Kuchroo; I R Cohen; H Weiner; M Schwartz
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

Review 2.  Rett syndrome and other autism spectrum disorders--brain diseases of immune malfunction?

Authors:  N C Derecki; E Privman; J Kipnis
Journal:  Mol Psychiatry       Date:  2010-02-23       Impact factor: 15.992

Review 3.  Failed central nervous system regeneration: a downside of immune privilege?

Authors:  Ingo Bechmann
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

4.  How promising is hematopoetic stem cell transplantation in multiple sclerosis?

Authors:  Reinhard Hohlfeld
Journal:  J Neurol       Date:  2002-09       Impact factor: 4.849

5.  The cellular response in neuroinflammation: The role of leukocytes, microglia and astrocytes in neuronal death and survival.

Authors:  Monica J Carson; J Cameron Thrash; Barbara Walter
Journal:  Clin Neurosci Res       Date:  2006-12

6.  Microglial inhibitory factor (MIF/TKP) mitigates secondary damage following spinal cord injury.

Authors:  Jaime Emmetsberger; Stella E Tsirka
Journal:  Neurobiol Dis       Date:  2012-05-14       Impact factor: 5.996

Review 7.  Macrophage migration inhibitory factor as a therapeutic target after traumatic spinal cord injury: a systematic review.

Authors:  Seyed Mohammad Piri; Zahra Ghodsi; Sina Shool; Ali Anjomshoa; Amir Azarhomayoun; Ehsan Jangholi; Hamid Reza Dehghan; Rasha Atlasi; Alexander R Vaccaro; Vafa Rahimi-Movaghar
Journal:  Eur Spine J       Date:  2021-01-24       Impact factor: 3.134

Review 8.  Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment.

Authors:  Gaylia Jean Harry; Andrew D Kraft
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-10       Impact factor: 4.481

Review 9.  [Multiple sclerosis: potential therapeutic options and update of ongoing studies].

Authors:  H Wiendl; H C Lehmann; R Hohlfeld; H-P Hartung; B C Kieseier
Journal:  Nervenarzt       Date:  2004-06       Impact factor: 1.214

10.  Modulation of the major histocompatibility complex by neural stem cell-derived neurotrophic factors used for regenerative therapy in a rat model of stroke.

Authors:  Chongran Sun; Han Zhang; Jin Li; Hua Huang; Hongbin Cheng; Yajie Wang; Ping Li; Yihua An
Journal:  J Transl Med       Date:  2010-08-20       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.